CoChat

Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development

Open access
Kiaie, Seyed Hossein, Sanaei, Mohammad Javad, Heshmati, Masoud, Asadzadeh, Zahra, Azimi, Iman, Hadidi, Saleh, Jafari, Reza, Baradaran, Behzad · 2021 · Acta Pharmaceutica Sinica B
Cited by 36

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Immunotherapy has been recently considered as a promising alternative for cancer treatment. Indeed, targeting of immune checkpoint (ICP) strategies have shown significant success in human malignancies. However, despite remarkable success of cancer immunotherapy in pancreatic cancer (PCa), many of the developed immunotherapy methods show poor therapeutic outcomes in PCa with no or few effective treatment options thus far. In this process, immunosuppression in the tumor microenvironment (TME) is found to be the main obstacle to the effectiveness of antitumor immune response induced by an immunotherapy method. In this paper, the latest findings on the ICPs, which mediate immunosuppression in the TME have been reviewed. In addition, different approaches for targeting ICPs in the TME of PCa have been discussed. This review has also synopsized the cutting-edge advances in the latest studies to clinical applications of ICP-targeted therapy in PCa.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.apsb.2020.12.011

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 36

Metadata

Authors
Kiaie, S. H., Sanaei, M. J., Heshmati, M., Asadzadeh, Z., Azimi, I., Hadidi, S., Jafari, R., & Baradaran, B.
Venue
Acta Pharmaceutica Sinica B
Publisher
Elsevier BV
Published
2021-05
Volume
11
Issue
5
Pages
1083-1097
ISSN
2211-3835 (ISSN-L)
OpenAlex
W3112832680
Cited by
36
References
30
FWCI
1.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development. https://app.cochat.ai/papers/10.1016/j.apsb.2020.12.011
The paper
Kiaie, S. H., Sanaei, M. J., Heshmati, M., Asadzadeh, Z., Azimi, I., Hadidi, S., Jafari, R., & Baradaran, B. (2021). Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2020.12.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.